Results 1 to 10 of about 142,557 (303)

Circulating Muscle Markers for Sarcopenia in Peritoneal Dialysis [PDF]

open access: yesInternational Journal of Nephrology
Sarcopenia, characterized by the progressive decline in muscle mass and function, is an important complication among patients undergoing peritoneal dialysis (PD).
Lixing Xu   +5 more
doaj   +2 more sources

The association of iron status on clinical outcomes in peritoneal dialysis: a retrospective study over 10 years [PDF]

open access: yesRenal Failure
Iron deficiency and overload are common in kidney disease. Although the relation between iron status and clinical outcome is well reported in hemodialysis, there are few publications in peritoneal dialysis (PD).
Vanessa Wing-Lam Tao   +5 more
doaj   +2 more sources

Peritoneal Dialysis

open access: goldNursing Forum, 1965
Eileen L. Shea
openalex   +3 more sources

Peritoneal Dialysis [PDF]

open access: yesRevista da Associação Médica Brasileira, 2020
SUMMARY Peritoneal dialysis (PD) is a renal replacement therapy based on infusing a sterile solution into the peritoneal cavity through a catheter and provides for the removal of solutes and water using the peritoneal membrane as the exchange surface.
Maria Claudia Cruz Andreoli   +1 more
openaire   +3 more sources

Peritoneal Dialysis Guidelines 2019 Part 1 (Position paper of Japanese Society of Dialysis Therapy)

open access: yesRenal Replacement Therapy, 2021
Approximately 10 years have passed since the Peritoneal Dialysis Guidelines were formulated in 2009. Much evidence has been reported during the succeeding years, which were not taken into consideration in the previous guidelines, e.g., the next ...
Yasuhiko Ito   +24 more
doaj   +1 more source

Topical application of mupirocin to exit sites in patients on peritoneal dialysis: a systematic review and meta-analysis of randomized controlled trials

open access: yesRenal Replacement Therapy, 2020
Background The International Society for Peritoneal Dialysis guidelines recommends the topical application of antibiotics on the exit site for the prevention of peritoneal dialysis (PD)-related infections.
Yoko Obata   +11 more
doaj   +1 more source

The impact of intraperitoneal antibiotic administration in patients with peritoneal dialysis-related peritonitis: systematic review and meta-analysis

open access: yesRenal Replacement Therapy, 2020
Background Peritonitis is a common and clinically important complication in patients receiving peritoneal dialysis (PD). Antibiotic administration is essential for PD-related peritonitis, but routes of administration have not been established enough ...
Kohkichi Morimoto   +10 more
doaj   +1 more source

10-year-long survival in a PD patient with severe calcifying encapsulating peritoneal sclerosis treated with tamoxifen: a case-report

open access: yesBMC Nephrology, 2020
Background Encapsulating-peritoneal-sclerosis (EPS) is a rare, but serious and life-threatening complication of peritoneal dialysis (PD). Treatment of EPS consists of discontinuation of PD and maintenance of nutritional status, whereas the role of ...
Vassilios Liakopoulos   +5 more
doaj   +1 more source

A single weekly Kt/Vurea target for peritoneal dialysis patients does not provide an equal dialysis dose for all [PDF]

open access: yes, 2016
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.Dialysis adequacy is traditionally based on urea clearance, adjusted for total body volume (Kt/Vurea), and clinical guidelines recommend a Kt/Vurea ...
Davenport, Andrew   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy